CEGEDIM SA (CGM.PA) Stock Fundamental Analysis

EPA:CGM • FR0000053506

10.4 EUR
-0.2 (-1.89%)
Last: Sep 3, 2025, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CGM. CGM was compared to 10 industry peers in the Health Care Technology industry. CGM may be in some trouble as it scores bad on both profitability and health. CGM is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year CGM has reported negative net income.
  • In the past year CGM had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: CGM reported negative net income in multiple years.
  • CGM had a positive operating cash flow in each of the past 5 years.
CGM.PA Yearly Net Income VS EBIT VS OCF VS FCFCGM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

  • The Return On Assets of CGM (-1.49%) is comparable to the rest of the industry.
  • CGM has a Return On Equity (-5.56%) which is in line with its industry peers.
  • CGM has a Return On Invested Capital of 4.46%. This is comparable to the rest of the industry: CGM outperforms 45.45% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CGM is significantly below the industry average of 8.41%.
  • The last Return On Invested Capital (4.46%) for CGM is above the 3 year average (2.87%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -1.49%
ROE -5.56%
ROIC 4.46%
ROA(3y)-0.25%
ROA(5y)0.74%
ROE(3y)-1.16%
ROE(5y)2.61%
ROIC(3y)2.87%
ROIC(5y)3.89%
CGM.PA Yearly ROA, ROE, ROICCGM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

  • The Operating Margin of CGM (5.75%) is comparable to the rest of the industry.
  • CGM's Operating Margin has declined in the last couple of years.
  • With a Gross Margin value of 20.07%, CGM is not doing good in the industry: 81.82% of the companies in the same industry are doing better.
  • CGM's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 5.75%
PM (TTM) N/A
GM 20.07%
OM growth 3Y-6.64%
OM growth 5Y-3.53%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.96%
GM growth 5Y-1.7%
CGM.PA Yearly Profit, Operating, Gross MarginsCGM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CGM is still creating some value.
  • CGM has more shares outstanding than it did 1 year ago.
  • CGM has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for CGM is higher compared to a year ago.
CGM.PA Yearly Shares OutstandingCGM.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
CGM.PA Yearly Total Debt VS Total AssetsCGM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • CGM has an Altman-Z score of 1.27. This is a bad value and indicates that CGM is not financially healthy and even has some risk of bankruptcy.
  • CGM has a Altman-Z score of 1.27. This is comparable to the rest of the industry: CGM outperforms 45.45% of its industry peers.
  • The Debt to FCF ratio of CGM is 27.31, which is on the high side as it means it would take CGM, 27.31 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 27.31, CGM is in line with its industry, outperforming 54.55% of the companies in the same industry.
  • A Debt/Equity ratio of 1.14 is on the high side and indicates that CGM has dependencies on debt financing.
  • CGM has a worse Debt to Equity ratio (1.14) than 72.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF 27.31
Altman-Z 1.27
ROIC/WACC1.08
WACC4.14%
CGM.PA Yearly LT Debt VS Equity VS FCFCGM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • CGM has a Current Ratio of 0.99. This is a bad value and indicates that CGM is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of CGM (0.99) is worse than 63.64% of its industry peers.
  • A Quick Ratio of 0.97 indicates that CGM may have some problems paying its short term obligations.
  • CGM's Quick ratio of 0.97 is on the low side compared to the rest of the industry. CGM is outperformed by 63.64% of its industry peers.
Industry RankSector Rank
Current Ratio 0.99
Quick Ratio 0.97
CGM.PA Yearly Current Assets VS Current LiabilitesCGM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • CGM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -97.97%.
  • CGM shows a small growth in Revenue. In the last year, the Revenue has grown by 6.25%.
  • CGM shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.38% yearly.
EPS 1Y (TTM)-97.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1194.13%
Revenue 1Y (TTM)6.25%
Revenue growth 3Y7.65%
Revenue growth 5Y5.38%
Sales Q2Q%6.51%

3.2 Future

  • The Earnings Per Share is expected to grow by 21.86% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 3.41% on average over the next years.
EPS Next Y-1.77%
EPS Next 2Y20.1%
EPS Next 3Y21.86%
EPS Next 5YN/A
Revenue Next Year1.46%
Revenue Next 2Y2.88%
Revenue Next 3Y3.41%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CGM.PA Yearly Revenue VS EstimatesCGM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
CGM.PA Yearly EPS VS EstimatesCGM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • CGM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • The Price/Forward Earnings ratio is 9.28, which indicates a very decent valuation of CGM.
  • CGM's Price/Forward Earnings ratio is rather cheap when compared to the industry. CGM is cheaper than 90.91% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.06. CGM is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 9.28
CGM.PA Price Earnings VS Forward Price EarningsCGM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CGM is valued cheaper than 100.00% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CGM indicates a rather cheap valuation: CGM is cheaper than 90.91% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 12.29
EV/EBITDA 3.23
CGM.PA Per share dataCGM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30 40

4.3 Compensation for Growth

  • CGM's earnings are expected to grow with 21.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.1%
EPS Next 3Y21.86%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for CGM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

CEGEDIM SA

EPA:CGM (9/3/2025, 7:00:00 PM)

10.4

-0.2 (-1.89%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)N/A
Earnings (Next)09-25
Inst Owners17.29%
Inst Owner ChangeN/A
Ins Owners57.12%
Ins Owner ChangeN/A
Market Cap146.64M
Revenue(TTM)654.50M
Net Income(TTM)-14.71M
Analysts48.89
Price Target12.92 (24.23%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.56%
PT rev (3m)-7.32%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-24.49%
EPS NY rev (3m)-24.49%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.42%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 9.28
P/S 0.22
P/FCF 12.29
P/OCF 1.44
P/B 0.55
P/tB N/A
EV/EBITDA 3.23
EPS(TTM)-1.07
EYN/A
EPS(NY)1.12
Fwd EY10.78%
FCF(TTM)0.85
FCFY8.14%
OCF(TTM)7.22
OCFY69.45%
SpS46.42
BVpS18.75
TBVpS-11.55
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.49%
ROE -5.56%
ROCE 6.06%
ROIC 4.46%
ROICexc 4.84%
ROICexgc 19.22%
OM 5.75%
PM (TTM) N/A
GM 20.07%
FCFM 1.82%
ROA(3y)-0.25%
ROA(5y)0.74%
ROE(3y)-1.16%
ROE(5y)2.61%
ROIC(3y)2.87%
ROIC(5y)3.89%
ROICexc(3y)3.13%
ROICexc(5y)4.15%
ROICexgc(3y)11.62%
ROICexgc(5y)15.26%
ROCE(3y)3.91%
ROCE(5y)5.29%
ROICexgc growth 3Y0.21%
ROICexgc growth 5Y-3.19%
ROICexc growth 3Y-3.24%
ROICexc growth 5Y-2.52%
OM growth 3Y-6.64%
OM growth 5Y-3.53%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.96%
GM growth 5Y-1.7%
F-Score3
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF 27.31
Debt/EBITDA 2.3
Cap/Depr 96.22%
Cap/Sales 13.74%
Interest Coverage 4.24
Cash Conversion 77.7%
Profit Quality N/A
Current Ratio 0.99
Quick Ratio 0.97
Altman-Z 1.27
F-Score3
WACC4.14%
ROIC/WACC1.08
Cap/Depr(3y)92.57%
Cap/Depr(5y)94.88%
Cap/Sales(3y)13.24%
Cap/Sales(5y)13.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-97.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1194.13%
EPS Next Y-1.77%
EPS Next 2Y20.1%
EPS Next 3Y21.86%
EPS Next 5YN/A
Revenue 1Y (TTM)6.25%
Revenue growth 3Y7.65%
Revenue growth 5Y5.38%
Sales Q2Q%6.51%
Revenue Next Year1.46%
Revenue Next 2Y2.88%
Revenue Next 3Y3.41%
Revenue Next 5YN/A
EBIT growth 1Y79.81%
EBIT growth 3Y0.5%
EBIT growth 5Y1.66%
EBIT Next Year278.79%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-46.81%
FCF growth 3Y-27.43%
FCF growth 5YN/A
OCF growth 1Y4.01%
OCF growth 3Y2%
OCF growth 5Y28.33%

CEGEDIM SA / CGM.PA FAQ

What is the fundamental rating for CGM stock?

ChartMill assigns a fundamental rating of 3 / 10 to CGM.PA.


What is the valuation status of CEGEDIM SA (CGM.PA) stock?

ChartMill assigns a valuation rating of 5 / 10 to CEGEDIM SA (CGM.PA). This can be considered as Fairly Valued.


What is the profitability of CGM stock?

CEGEDIM SA (CGM.PA) has a profitability rating of 3 / 10.


Can you provide the dividend sustainability for CGM stock?

The dividend rating of CEGEDIM SA (CGM.PA) is 0 / 10 and the dividend payout ratio is 0%.